Free Trial

biote (BTMDW) Competitors

biote logo
$0.02 0.00 (0.00%)
As of 05/21/2025

BTMDW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BCTXW, CELUW, and CINGW

Should you be buying biote stock or one of its competitors? The main competitors of biote include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry.

biote vs.

biote (NASDAQ:BTMDW) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, community ranking, dividends and earnings.

In the previous week, biote's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
biote Neutral
180 Life Sciences Neutral

biote and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
bioteN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
biote$199.38MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
bioteN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

biote beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get biote News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTMDW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTMDW vs. The Competition

MetricbioteMedicinal Chemicals IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$800.30M$2.04B$8.39B
Dividend YieldN/AN/A2.64%4.11%
P/E RatioN/A29.8822.9219.71
Price / SalesN/A7.4260.71120.53
Price / CashN/AN/A51.7234.62
Price / BookN/AN/A2.064.50
Net IncomeN/AN/A-$292.00M$248.22M
7 Day PerformanceN/A-7.21%-0.39%-0.78%
1 Month PerformanceN/A41.31%8.96%11.53%
1 Year PerformanceN/AN/A13.38%8.99%

biote Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTMDW
biote
N/A$0.02
flat
N/A-94.7%$0.00$199.38M0.00N/AGap Up
ATNFW
180 Life Sciences
N/A$0.01
-3.2%
N/A+7.1%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
+282.4%
N/AN/A$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.10
-24.2%
N/AN/A$0.00$20,729.000.0040Gap Down
ALVOW
Alvotech
N/A$1.77
-1.1%
N/A-36.7%$0.00$489.68M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
+2.5%
N/A-80.8%$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.10
-25.5%
N/AN/A$0.00$37.32M0.0070Gap Up
BCTXW
BriaCell Therapeutics
N/A$0.05
-17.1%
N/A-80.9%$0.00N/A0.008Gap Down
CELUW
Celularity
N/A$0.04
-6.3%
N/A+150.0%$0.00$54.22M0.00220Gap Down
CINGW
Cingulate
N/A$0.03
-13.6%
N/A+24.8%$0.00N/A0.0020

Related Companies and Tools


This page (NASDAQ:BTMDW) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners